Science Arts, Inc. (TYO:4412)
Japan · Delayed Price · Currency is JPY 1,091.00
-25.00 (-2.24%)
Jul 30, 2026, 9:01 AM JST
Science Arts Income Statement
Financials in millions JPY. Fiscal year is September - August.
Millions JPY. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
| 2,058 | 1,654 | 1,184 | 771 | 659 | 365 | |
Revenue Growth | 40.38% | 39.70% | 53.57% | 16.99% | 80.55% | 64.41% |
Cost of Revenue | 788 | 645 | 507 | 281 | 224 | 101 |
Gross Profit | 1,270 | 1,009 | 677 | 490 | 435 | 264 |
Selling, General & Admin | 1,035 | 865 | 682 | 519 | 412 | 354 |
Research & Development | 24 | 24 | 15 | 19 | 9 | 7 |
Operating Expenses | 1,072 | 902 | 709 | 557 | 424 | 362 |
Operating Income | 198 | 107 | -32 | -67 | 11 | -98 |
Interest Expense | -1 | -1 | -1 | - | - | - |
Interest & Investment Income | 3 | 1 | - | - | - | - |
Currency Exchange Gain (Loss) | -2 | - | -1 | - | - | - |
Other Non Operating Income (Expenses) | - | -14 | 1 | -2 | -2 | 3 |
EBT Excluding Unusual Items | 198 | 93 | -33 | -69 | 9 | -95 |
Gain (Loss) on Sale of Investments | - | - | - | -4 | - | - |
Pretax Income | 198 | 93 | -33 | -73 | 9 | -95 |
Income Tax Expense | -5 | -19 | -2 | 8 | - | - |
Net Income | 203 | 112 | -31 | -81 | 9 | -95 |
Net Income to Common | 203 | 112 | -31 | -81 | 9 | -95 |
Net Income Growth | 420.51% | - | - | - | - | - |
Shares Outstanding (Basic) | 8 | 8 | 7 | 7 | 3 | 3 |
Shares Outstanding (Diluted) | 8 | 8 | 7 | 7 | 3 | 3 |
Shares Change | 9.65% | 19.02% | 0.11% | 95.84% | 10.59% | 3.82% |
EPS (Basic) | 25.05 | 14.29 | -4.71 | -12.32 | 2.81 | -31.29 |
EPS (Diluted) | 24.83 | 14.29 | -4.71 | -12.32 | 2.68 | -31.29 |
EPS Growth | 374.72% | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | May '26 May 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 |
Free Cash Flow | - | 272 | -46 | -86 | 96 | -97 |
Free Cash Flow Per Share | - | 34.71 | -6.99 | -13.08 | 28.59 | -31.94 |
Gross Margin | 61.71% | 61.00% | 57.18% | 63.55% | 66.01% | 72.33% |
Operating Margin | 9.62% | 6.47% | -2.70% | -8.69% | 1.67% | -26.85% |
Profit Margin | 9.86% | 6.77% | -2.62% | -10.51% | 1.37% | -26.03% |
Free Cash Flow Margin | - | 16.45% | -3.89% | -11.15% | 14.57% | -26.57% |
EBITDA | 214.5 | 122 | -19 | -46 | 14 | -97 |
EBITDA Margin | 10.42% | 7.38% | -1.60% | -5.97% | 2.12% | -26.57% |
D&A For EBITDA | 16.5 | 15 | 13 | 21 | 3 | 1 |
EBIT | 198 | 107 | -32 | -67 | 11 | -98 |
EBIT Margin | 9.62% | 6.47% | -2.70% | -8.69% | 1.67% | -26.85% |
Advertising Expenses | - | 70 | 107 | - | 34 | 82 |